Patents by Inventor Fred Joseph Schnell

Fred Joseph Schnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190330624
    Abstract: Antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon 44 skipping are described.
    Type: Application
    Filed: December 7, 2018
    Publication date: October 31, 2019
    Inventors: Richard K. Bestwick, Diane Elizabeth Frank, Fred Joseph Schnell
  • Publication number: 20170369876
    Abstract: Antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon 44 skipping are described.
    Type: Application
    Filed: February 1, 2017
    Publication date: December 28, 2017
    Inventors: Richard K. BESTWICK, Diane Elizabeth FRANK, Fred Joseph SCHNELL
  • Publication number: 20140329881
    Abstract: Antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon 44 skipping are described.
    Type: Application
    Filed: March 14, 2014
    Publication date: November 6, 2014
    Applicant: Sarepta Therapeutics, Inc.
    Inventors: Richard K. Bestwick, Diane Elizabeth Frank, Fred Joseph Schnell